Answers are grounded in this paper and cite their sources.
Subgroup analyses are insufficiently described in the protocols of randomised controlled trials submitted to research ethics committees, and investigators rarely specify the anticipated direction of subgroup effects. More than one third of statements in publications of randomised controlled trials about subgroup prespecification had no documentation in the corresponding protocols. Definitive judgments regarding credibility of claimed subgroup effects are not possible without access to protocols and analysis plans of randomised controlled trials.
No takes yet. Share an insight, caveat, or question.
Kasenda et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: